MORANDI, BARBARA
 Distribuzione geografica
Continente #
EU - Europa 3.001
AS - Asia 145
SA - Sud America 17
NA - Nord America 10
AF - Africa 2
Totale 3.175
Nazione #
IT - Italia 2.999
SG - Singapore 64
VN - Vietnam 40
CN - Cina 35
BR - Brasile 11
US - Stati Uniti d'America 8
AR - Argentina 5
IN - India 2
AT - Austria 1
BB - Barbados 1
BD - Bangladesh 1
CO - Colombia 1
HK - Hong Kong 1
ID - Indonesia 1
IQ - Iraq 1
MX - Messico 1
RW - Ruanda 1
SN - Senegal 1
UA - Ucraina 1
Totale 3.175
Città #
Genova 1.859
Genoa 689
Rapallo 263
Vado Ligure 178
Singapore 17
Hanoi 12
Ho Chi Minh City 12
Beijing 9
Ashburn 8
Bordighera 7
Da Nang 2
Haiphong 2
Hải Dương 2
Belford Roxo 1
Bella Vista 1
Biên Hòa 1
Bridgetown 1
Bucaramanga 1
Buon Ma Thuot 1
Caraíbas 1
Chennai 1
Comodoro Rivadavia 1
Dakar 1
Duque de Caxias 1
Erbil 1
Hermosillo 1
Hong Kong 1
Hyderabad 1
Hưng Yên 1
José C. Paz 1
João Pessoa 1
Jurema 1
Kigali 1
Kyiv 1
Nam Định 1
Nha Trang 1
Ninh Bình 1
Petrópolis 1
Puerto Madryn 1
San Nicolás de los Arroyos 1
Santa Maria 1
Santo André 1
São Paulo 1
Tianjin 1
Traiskirchen 1
Uberlândia 1
Viamão 1
Vũng Tàu 1
Totale 3.095
Nome #
A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells 192
T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties 171
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 167
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 163
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 155
Novel perspectives on dendritic cell-based immunotherapy of cancer 155
Characterization of human afferent lymph dendritic cells from seroma fluids. 155
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 154
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 152
IFN-alpha mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome 147
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 146
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells 141
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. 137
Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells 134
Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. 132
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. 132
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell ig-like receptors and become cytolytic. 129
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis 124
Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses 124
NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion 99
The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2. 99
Natural Killer cells infiltrating human non-small cell lung cancer are enriched in CD56bright CD16- cells and display an impaired capability to kill tumor cells 99
Eosinophil granulocytes accounf for indoleamine 2,3-Dioxygenase-mediated immune escape in human non-small cell lung cancer. 90
Totale 3.197
Categoria #
all - tutte 10.246
article - articoli 10.246
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 10 3 13 15 16 14 9
2021/2022307 9 25 28 29 15 13 20 87 15 28 10 28
2022/2023296 23 36 6 17 42 44 3 33 51 1 37 3
2023/2024177 2 21 7 27 16 32 5 8 6 10 22 21
2024/2025463 2 32 29 30 44 48 47 83 8 22 61 57
2025/2026380 83 18 56 57 144 22 0 0 0 0 0 0
Totale 3.197